Embecta Corp.
Financial highlights
| Metric | FY 09/30/25 | FY 09/30/24 | FY 09/30/23 | FY 09/30/22 | FY 09/30/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $1.1 | $1.1 | $1.1 | $1.1 | $1.2 |
| Operating income | $0.2 | $0.2 | $0.2 | $0.3 | $0.5 |
| Net income | $0.1 | $0.1 | $0.1 | $0.2 | $0.4 |
| Balance Sheet | |||||
| Total debt | $1.4 | $1.6 | $1.6 | $1.6 | $0.0 |
| Cash Flow Statement | |||||
| Free cash flow | $0.2 | $<0.1 | $<0.1 | $0.4 | $0.4 |
| Dividends | $<0.1 | $<0.1 | $<0.1 | $<0.1 | $0.0 |
Shares outstanding 56.7M · Free float 98.6%
Annual filing data through FY ended September 30, 2025; float as of October 6, 2026.
Coverage
September 28, 2026
QBook
Stronger demand supports expansion as pricing diverges
August 14, 2026
Insider Signal
Chemours and Chiron Lead Weekly Insider Buying Clusters
August 14, 2026
Industry Earnings Roundup
Healthcare Earnings: Demand Surges, Costs Bite Back
July 4, 2026
Guidance Season
Chipmakers Lead a Guidance Season Almost Free of Cuts